evolcSign inStart free
Menu

Histologix

GLP- and GCP-compliant tissue analysis and histopathology services for pharmaceutical and biotechnology companies

Nottingham, United KingdomFounded 2005histologix.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-08

About Histologix

HistologiX provides histology, immunohistochemistry, immunofluorescence, in situ hybridisation and digital pathology services, including quantitative image analysis and tissue cross-reactivity studies. It supports projects from discovery and preclinical toxicology through clinical trials.

Its customers include pharmaceutical and biotechnology companies worldwide. Services are delivered through contracted laboratory research and analysis projects.

Formed in 2005, HistologiX is based in Nottingham, UK. It operates laboratories in the UK and holds a Human Tissue Authority licence to source and store human tissue.

Product: Contract histology, immunohistochemistry, immunofluorescence, tissue cross-reactivity and digital pathology analysis services.

Jobs at Histologix

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Horizon Discovery Group

    Gene-editing reagents, engineered cell lines and reference standards for life sciences research and diagnostics
    Cambridge, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Hvivo Services

    Early-phase clinical trials, human challenge studies and lab services for biopharma and biotech sponsors
    London, United KingdomBiotech & pharmaFounded 1988
    New on Evolc

  • Hyfacol

    Medical-grade collagen manufacturing platform for advanced wound care and guided bone regeneration products
    Leeds, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc

  • Hypha Discovery

    Specialist CRO making drug and agrochemical metabolites, purifying compounds and running MetID studies for pharma clients
    Abingdon, United KingdomBiotech & pharmaFounded 2004
    New on Evolc

  • Ilc Therapeutics

    Develops hybrid interferon therapeutics, with lead candidate Alfacyte in development as an antiviral for RSV
    Edinburgh, United KingdomBiotech & pharmaFounded 2012
    New on Evolc

  • Imaging Endpoints

    Oncology imaging CRO that designs, reads and analyses imaging endpoints for pharma sponsors' clinical trials
    Harrow, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

CRM & customer data

  • HubSpotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.